lntraoperative hypothermia results largely from anesthetic-induced inhibition of tonic thermoregulatory vasoconstriction. Sufficient hypothermia, however, triggers peripheral vasoconstriction, which usually prevents further decrease in core temperature.
The thermoregulatory effects of all volatile anesthetics have been tested in adults and/or children, but different anesthetics have not been directly coinpared. We therefore evaluated thermoregulatory responses during enflurane, isoflurane, and halothane administration. Anesthesia was maintained with 1 minimum alveolar anesthetic concentration (MAC) of halothane, isoflurane, or enflurane in 27 patients undergoing intraabdominal surgery. Patients were maintained normovolemic and normocapnic but were allowed to cool passively. A forearm minus fingertip, skin-temperature gradient of 4°C identified significant vasoconstriction; the core temperature triggering vasoconstriction identified the threshold. Morphometric characteristics, initial core temperatures, ambient operating room temperatures, blood pressures, and anesthetic potencies were similar in each group. All eight patients given halothane vasoconstricted at a core temperature of 35.5 -C 0.6"C. Eight of the patients given isoflurane vasoconstricted at a core temperature of 35.2 2 0.5"C. However, two others did not at minimum core temperatures of 34.0 and 33.8"C. Only one patient given enflurane vasoconstricted at a core temperature of 34.6"C. The other six patients never vasoconstricted, at minimum core temperatures of 33.6 ? 0.4"C. Our data indicate that enflurane profoundly inhibits thermoregulatory responses in children. The mechanism for this extraordinary inhibition remains unknown but does not result from any obvious anesthetic pharmacology or thermoregulatory physiology. We conclude that LUIwarmed pediatric patients will become colder when anesthetized with enflurane than with halothane or isoflurane. (Anesth Analg 1996; 83:595-9) I n the absence of active warming (11, intraoperative hypothermia is common (2) and causes potentially serious complications (3). The reduction in core temperature immediately after induction of general anesthesia results largely from anesthetic-induced inhibition of tonic thermoregulatory vasoconstriction (4) and subsequent core-to-peripheral redistribution of body heat (5). Heat loss exceeding metabolic heat production then typically continues to reduce body temperature for several additional hours (6). Finally, reemergence of thermoregulatory vasoconstriction (in patients becoming sufficiently hypothermic) moderates further core hypothermia by decreasing cutaneous heat loss (7) and constraining metabolic heat to the core thermal compartment (8).
All general anesthetics so far tested significantly decrease the thermoregulatory threshold for vasoconstriction (i.e., the core temperature triggering vasoconstriction) (4,9-13). Because vasoconstriction is effective in minimizing additional core hypothermia (8), anesthetics causing relatively little thermoregulatory inhibition may be preferable in some patients.
The vasoconstriction thresholds for halothane have been determined in adults (9) and pediatric patients (10). Similarly, the vasoconstriction thresholds for isoflurane have been determined in adults (11) and infants and children (12). The vasoconstriction threshold during enflurane has been determined in adults (13) but not in pediatric patients. However, the thermoregulatory effects of these three anesthetics have not been directly compared in either adult or pediatric patients. ANALG 1996; 83:595-9 The volatile anesthetic enflurane is unique in producing electroencephalograph activation during steady-state administration. This activation may be sufficient to provoke seizure activity in pediatric patients (14) and may result in sympathetic nervous system activation. Nitrous oxide, which also causes sympathetic nervous system activation, impairs thermoregulatory control less than equipotent concentrations of isoflurane and sevoflurane (15). Similarly, anesthetic-induced thermoregulatory inhibition is reduced by painful stimulation-another sympathetic nervous system activator (13). These observations suggest that enflurane, like other drugs that activate the sympathetic nervous system, may inhibit thermoregulatory control less than other volatile anesthetics. Accordingly, we tested the hypothesis that the vasoconstriction threshold during enflurane anesthesia is higher than during comparable doses of isoflurane and halothane.
Methods
With approval from the Ethics Committee of the Hospital for Sick Children, we studied 27 ASA physical status I-II pediatric patients after obtaining written, informed consent from their parents. They were scheduled for elective urological surgery (mostly bilateral ureteral reimplantation).
None of the participants had a history of thyroid disease, dysautonomia, Raynaud's syndrome, or malignant hyperthermia. None of the patients were given surgical premedication. Each was anesthetized with one of the test anesthetics (halothane, isoflurane, or enflurane). Core temperature was allowed to decrease until the threshold for vasoconstriction was identified, core temperature reached 33"C, or surgery ended.
Anesthesia was induced with 70% nitrous oxide in oxygen, one of the test anesthetics (halothane, isoflurane, or enflurane), and vecuronium 0.1 mg/kg. Nitrous oxide administration was then discontinued, the trachea of each patient was intubated, and the lungs were mechanically ventilated with a tidal volume near 12 mL/kg and a respiratory rate sufficient to maintain an end-tidal Pco, near 35 mm Hg. Bupivacaine (l.O-1.25 mL/kg, 0.125%) was injected into the epidural space via a caudal approach immediately after induction of anesthesia. We have previously demonstrated that these doses of epidural bupivacaine produce a sympathetic blockade extending no higher than the 12th thoracic dermatome and do not alter thermoregulatory responses in infants (10). No airway heating or humidification was provided. Patients were randomly assigned to maintenance anesthesia with 1 minimum alveolar anesthetic concentration (MAC) of halothane, isoflurane, or enflurane. We considered 0.8% to be the MAC of halothane (16), 1.15% to be the MAC of isoflurane (17), and 1.7% to be the MAC of enflurane (18) . No thiopental or opioid was administered.
Supplemental vecuronium was administered as needed to maintain one to two twitches in response to supramaximal stimulation of the ulnar nerve at the wrist. Because hypovolemia also decreases peripheral perfusion, at least 10 mL * kg-' * h-' fluid was given intravenously and administered fluids were warmed to 37°C.
The patients were covered with a single layer of surgical draping, which decreases cutaneous heat loss -30% (19); no other warming measures were taken during the study period. Twenty minutes after significant vasoconstriction was observed, patients were actively rewarmed using a forced-air system (1,20). Subsequent anesthetic management was left to the discretion of the responsible anesthesiologist.
Ambient temperature was measured using a thermocouple positioned at the level of the patient, well away from any heat-producing equipment. Core temperature was recorded from the distal esophagus (21), starting immediately after induction of anesthesia (initial temperature).
Mean skin temperature was calculated from four sites: 0.3(Tchest + T,,,) + 0.2(Tthigh + Tcad (22).
Fingertip perfusion was evaluated using forearm minus fingertip, skin-temperature gradients. Perfusion was recorded from an arm exposed to the operating room environment and not having a blood pressure cuff or intravenous catheter. There is an excellent correlation between skin-temperature gradients and volume plethysmography (23). Temperatures were recorded from Mon-a-Therm@ thermocouples connected to a calibrated Iso-Thermex@ 16-channel electronic thermometer having an accuracy of O.l"C and a precision of O.Ol"C (Columbus Instruments International, Corp., Columbus, OH).
Blood pressure was determined oscillometrically at 5-min intervals. We used oscillometric rather than direct arterial blood pressure measurements to minimize the artifact induced by thermoregulatory vasoconstriction (24,25). Respiratory gas concentrations were quantified using a calibrated end-tidal gas analyzer (Datex Medical Instrumentation, Inc., Tewksbury, MA). Data were recorded at lo-min intervals, starting immediately before induction of anesthesia.
As in previous studies in pediatric patients (10,12), we considered a forearm minus fingertip, skintemperature gradient of 4°C to indicate significant thermoregulatory vasoconstriction. The distal esophageal temperature triggering significant vasoconstriction was considered the core-temperature threshold for this thermoregulatory defense. Morphometric data, initial core temperatures, ambient temperatures, and relative anesthetic potency (MAC fraction) were first averaged over time in each subject and then averaged among the patients given each type of anesthesia. Differences were evaluated using one-way analysis of variance and Sheffcs F-tests.
The fraction of patients who vasoconstricted (skin temperature 2 4°C) at any time during the study were compared using a 2 test with Yates correction for continuity. Vasoconstriction thresholds, times to constriction, and mean skin temperatures at the time of constriction in the patients given isoflurane and halothane were compared using two-tailed, unpaired t-tests. All values are expressed as mean + SD; differences were considered significant when P was < 0.01.
Results
Morphometric characteristics were comparable in the three groups. The initial core temperatures, ambient operating room temperatures, and blood pressures did not differ significantly in the three groups. Endtidal anesthetic potency (MAC fraction) also did not differ significantly (Table 1) .
All eight patients given halothane vasoconstricted at a core temperature of 35.5 2 0.6"C ( Table 2) . Eight of the patients given isoflurane vasoconstricted at a core temperature of 35.2 t 0.5"C. However, two others did not, at minimum core temperatures of 34.0 and 33.8"C. Only one patient given enflurane vasoconstricted at a core temperature of 34.6"C. The other six never vasoconstricted at minimum core temperatures of 33.6 + 0.4"C (Fig. 1) .
Discussion
Cutaneous and respiratory heat loss during surgery usually far exceeds metabolic heat production in unwarmed infants and children. These patients thus become progressively more hypothermic, at least until thermoregulatory defenses are reestablished. Nonshivering thermogenesis is an important thermoregulatory defense in infants and can double metabolic rate (26,27X However, halothane (and probably the other Patients given isoflurane and halothane vasoconstricted at comparable core temperatures.
All but one of the patients given enflurane, however, failed to vasoconstrict at minimum core temperatures of 33.6 t 0.4"C (P < 0.001). There were no statistically significant differences between the patients given isoflurane and halothane. In contrast, all but one of the patients given enflurane failed to vasoconstrict at minimum core temperatures of 33.6 t 0.4"C (P < 0.001).
volatile anesthetics) inhibits nonshivering thermogenesis peripherally (28), limiting the efficacy of the response during surgery. Arteriovenous shunt vasoconstriction is thus the major thermoregulatory defense during anesthesia and surgery. These shunts are loo-pm diameter anastamoses directly connecting arterioles and veins; consequently, they convey 10,000 times as much blood as an equal length of lo-pm ANALG 1996; 83:595-9 capillary (29). Although the shunts are largely restricted to the fingers and toes, they influence body heat distribution by changing total extremity blood flow.
Fortunately, shunt vasoconstriction-once initiated-is remarkably effective and usually prevents further core hypothermia (8,lO) . The core temperature triggering this effective thermoregulatory defense depends, however, on the type and dose of anesthetic administered (4,ll). Our data indicate that enflurane inhibited thermoregulatory vasoconstriction far more than comparable doses of isoflurane and halothane. This result is surprising and contrary to our hypothesis. The mechanism for this extraordinary inhibition remains unknown but does not result from any obvious anesthetic pharmacology or thermoregulatory physiology.
The clinical implication of these data are nonetheless clear: unwarmed pediatric patients will become colder when anesthetized with enflurane than with halothane or isoflurane.
It remains unclear whether the extraordinary thermoregulatory inhibition produced by enflurane is restricted to the pediatric population, because vasoconstriction thresholds during enflurane and isoflurane anesthesia have yet to be directly compared in adults. Nonetheless, thresholds with the two anesthetics have been evaluated in two similar studies: both were conducted in nonsurgical volunteers, without administration of nitrous oxide or epidural anesthesia, and with vasoconstriction defined by a skin-temperature gradient 1 4°C. In the first, the vasoconstriction threshold during administration of -0.8 MAC enflurane was 35.1 + 0.6"C (13). In the second, the vasoconstriction threshold during administration of -0.9 MAC isoflurane was 35.2 ? 0.8"C (30). These results suggest that thermoregulatory impairment induced by enflurane and isoflurane anesthesia is comparable in adults. Thermoregulatory defenses are characterized not only by thresholds, but also by gain (the rate at which response intensity increases) and maximum response intensity. We tested neither gain nor maximum response intensity for practical reasons: doing so would require active cooling to temperatures well below those triggering vasoconstriction. The vasoconstriction threshold is formally defined as the core temperature initiating arteriovenous shunt constriction. Although skin-temperature gradients of 4°C indicate intense vasoconstriction (23), we used this value to avoid the potentially confounding effects of hypovolemia and inadequate anesthetic depth, both of which can cause mild vasoconstriction.
We have previously demonstrated that vasoconstriction is rare in normothermic patients (9,31). It is thus unlikely that nonthermoregulatory factors confounded our results. The MAC of volatile anesthetics varies with age. For example, the MAC of isoflurane decreases from 1.8% in infants to 1.6% in children before decreasing to its adult value of 1.15% (32). We have, however, previously demonstrated that thermoregulatory inhibition by halothane (10) and isoflurane (12) (administered in doses not corrected for patient age) is comparable in infants, children, and adults. Because the age dependence of enflurane remains unknown, we used the adult values for all three tested anesthetics. It is unlikely, however, that the age dependence of enflurane differs markedly from that of halothane and isoflurane. MAC decreases in hypothermic patients (33), although the decrease is only =5%/V.
As in previous studies (9,10,12), we did not correct for the effects of core temperature of anesthetic potency because it is not established that the thermoregulatory and anesthetic effects change comparably.
In summary, our data indicate that enflurane profoundly inhibits thermoregulatory responses in children. The mechanism for this extraordinary inhibition remains unknown.
However, the clinical implication of these data are nonetheless clear: unwarmed pediatric patients will become colder when anesthetized with enflurane than with halothane or isoflurane.
